Curing childhood acute myeloid leukemia (AML) at the half-way point: Promises to keep and miles to go before we sleep

Pediatric Blood and Cancer

Volumn 46, Issue 5, 2006, Pages 565-569

  Woods, William G ^a,b  

^a EMORY UNIVERSITY   (United States)

^b AFLAC   (United States)

Author keywords

Acute myeloid leukemia; Bone marrow transplantation; Childhood leukemia; Leukemia experimental therapy; Leukemia induction therapy

Indexed keywords

ANTIBODY CONJUGATE; CYTARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW TRANSPLANTATION; CANCER MORTALITY; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; DONOR; DRUG MEGADOSE; HUMAN; LEUKEMIA REMISSION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIBLING; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ACUTE DISEASE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; DISEASE-FREE SURVIVAL; ENZYME INHIBITORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID; REMISSION INDUCTION; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33645304577     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20646     Document Type: Review

References (18)

1. Chard RL, Finklestein JZ, Sonley MJ, et al. Increased survival in childhood acute non-lymphocytic leukemia after treatment with prednisolone, cytosine arabinoside, 6-thioguanine, cyclophosphamide and oncovin (PATCO) combination chemotherapy. Med Pediatr Oncol 1978;4:263-273.
2. Sanders JE, Thomas ED, Buckner CD, et al. Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: An update. Blood 1985;66:460-462.
3. Nesbit ME, Buckley JD, Feig SA, et al. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: A report from the children's cancer group. J Clin Oncol 1994;12:127-135.
4. Woods WG, Kobrinsky N, Buckley JD, et al. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: A report from the Children's Cancer Group. Blood 1996;87:4979-4989.
5. Woods WG, Kobrinsky N, Buckley J, et al. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: A Children's Cancer Group Pilot Study. J Clin Oncol 1993;11:1448-1457.
6. Lange BJ, Smith FO, Dinndorf PA, et al. Outcomes in CCG-2961, a Children's Cancer Group Phase III Trial for Untreated Acute Myeloid Leukemia (AML). Presented at the Am Soc of Hematology (2961 Abstract submitted 2005).
7. Creutzig U, Ritter J, Zimmermann M, et al. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: Results of study acute myeloid leukemia-Berlin-Frankfurt-Münster 93. J Clin Oncol 2001;19:2705-2713.
8. Stevens RF, Hann IM, Wheatley K, et al. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: Results of the United Kingdom Medical Research Council's 10th AML trial. Br J Haematol 1998;101:130-140.
9. Hann IM, Webb DKW, Gibson BES, et al. MRC trials in childhood acute myeloid leukaemia. Ann Hematol 2004;83:S108-S112.
10. Woods WG, Ruymann FB, Lampkin BC, et al. The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia. Cancer 1990;66:1106-1113.
11. Wells RJ, Woods WG, Buckley JD, et al. Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: A Children's Cancer Group Study. J Clin Oncol 1994;12:2367-2377.
12. Amadori S, Testi AM, Arico M, et al. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. J Clin Oncol 1993;11:1046-1054.
13. Ravindranath Y, Yeager AM, Chang MN, et al. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. N Engl J Med 1996;334:1428-1434.
14. Boissel N, Auclerc MF, Lheritier V, et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 2003;21:774-780.
15. Woods WG, Alonzo T, Lange BJ, et al. Acute myeloid leukemia (AML) in adolescents and young adults (AYAs): A comparison of outcomes between patients treated on childhood or adult protocols. Presented at the 2001 annual meeting of the American Society of Hematology, Orlando, FL. Blood 2001;98:462a-463a.
16. Davies SM, Robison LL, Buckley JD, et al. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J Clin Oncol 2001;19:1279-1287.
17. Meshinchi S, Woods WG, Stirewalt DL, et al. Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatrie acute myeloid leukemia. Blood 2001;97:89-94.
18. + acute myeloid leukemia. Blood 2005;106:1183-1188.